Stimulant drug treatments for Attention Deficit/Hyperactivity Disorder (ADHD) have been a particular target of ethical controversy and debate. Bioethicists have raised concerns about the implications of stimulant drug treatment for child authenticity, individuality, and enhancement. There is at present little empirical evidence to support or deny these concerns. This article presents data from a pilot interview study that investigated children's moral self-understandings in relation to ADHD diagnosis and stimulant drug treatment, with a focus on children's understandings of their authentic selves. Stimulant drug treatment does not appear to undermine a child's sense of personal authenticity: In this study, children reported that they believed a core dimension of their `real' selves was persistently `bad', despite medication. This finding complicates two bioethical assumptions: That the authentic person is inherently good, and that there is inherent value in the experience of having access to a core, authentic dimension of oneself. Some important preliminary clinical implications of these findings are discussed.
Abbey, R. (2000). CharlesTaylor. Teddington: Acumen Publishing.
2.
Alderson, P. (1993). Children's consent to surgery. London: Open University Press.
3.
Brock. D. (1998). Enhancements of human function: Some distinctions for policy makers. In E. Case (Ed.), Intellectual development: Birth to adulthoodNew York: Academic Press.
4.
Bussing, R., Zima, B.T., & Perwien, A.R. (2000). Self-esteem in special education children at high risk for ADHD: The role of psychosocial variables, disorder characteristics, and medication use. Journal of the American Academy of Child and Adolescent Psychiatry, 39(10), 1260—1269.
5.
Caspi, A., McClay, J., Moffitt, T., Mill, J., Martin, J., Craig, I., Taylor, A., & Poulton, R. (2002). Role of genotype in the cycle of violence in maltreated children. Science, 297, 851—854.
6.
Cooper, P., & Shea, T. (1998). Pupils' perceptions of AD/HD. Emotional and Behavioural Difficulties, 3(3), 36—48.
7.
Dobson, R. (2000). NICE issues new guidelines on Ritalin. British Medical Journal, 321, 1100.
8.
Elliot, C. (2003). Better than well. New York : Norton.
9.
Fukuyama, F. (2002). Our posthuman future: Consequences of the biotechnology revolution. London: Profile Books .
10.
Gergen, K. (1991). The saturated self. New York : Basic Books.
11.
Gilligan, C., Rogers, A., & Tolman, D. (1991). Women, girls and psychotherapy: Reframing resistance . New York: Haworth Press.
12.
Glaser, B. (1978). Theoretical sensitivity: Advances in the methodology of grounded theory. Mill Valley, CA: Sociology Press.
13.
Greene, S. (2005). Researching children's experience: Conceptual and methodological issues. In S. Greene & D. Hogan (Eds.), Researching children's experience (pp. 1—21). London: SAGE Publications.
14.
Griffin, S. (1992). Structural analysis of the development of the inner world: A neo-structural analysis of the development of intrapersonal intelligence. In R. Case (Ed.), The mind's staircase (pp. 189—206). Hillsdale, NJ: Erlbaum.
15.
Harter, S. (1999). The construction of self: A developmental perspective . New York: Guilford.
16.
Hechtman, L., Abikoff, H., Klein, R., Weiss, G., et al. (2004). Academic achievement and emotional status of children treated with long-term methylphenidate and multimodal psychosocial treatment: Methylphenidate and multimodal psychosocial treatment in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 43(7), 812—819.
17.
Henwood, K.L., & Pidgeon, N.F. (2003). Grounded theory in psychological research. In P. Camic, L. Yardley, & J.E. Rhodes (Eds.), Qualitative research in psychology: Expanding perspectives in methodology and design (pp. 131—155) Washington, DC: APA.
18.
Hogan, D. (2005). Researching `the child' in developmental psychology . In S. Greene & D. Hogan (Eds.), Researching children's experience (pp. 22—41). London: SAGE Publications .
19.
Honig, P., & Jaffa, T. (2000). Consent in relation to the treatment of eating disorders. Psychiatric Bulletin, 24, 409—411.
20.
Hoza, B., Pelham, W.E., Milich, R., Pillow, D., & McBride, K. (1993). The self-perceptions and attributions of attention deficit hyperactivity disordered and nonreferred boys. Journal of Abnormal Child Psychology, 21(3), 271—286.
21.
National Institutes of Clinical Excellence. [NICE]. (2000). Please refer to http://www.nice.org.uk/page.aspx?0=TA013 .
22.
President's Council on Bioethics. (2003). Beyond therapy: Biotechnology and the pursuit of happiness. New York: Dana Foundation.
23.
Rapoport, J., Buchsbaum, M.S., Zahn,T.P., Weingartner, H., Ludlow, C., & Mikkelsen, E.J. (1978). Dextroamphetamine: Cognitive and behavioural effects in normal prepubertal boys. Science , 199, 560—563.
24.
Singh, I. (2003). Boys will be boys: Fathers' perspectives on ADHD symptoms, diagnosis and drug treatment. Harvard Review of Psychiatry, 11(6), 308—316.
25.
Singh, I. (2004). Doing their jobs: Mothering with Ritalin in a culture of mother-blame. Social Science and Medicine, 59(6), 1193—1205.
26.
Singh, I. (2005). Will the `real' boy please behave: Dosing dilemmas for parents of boys with ADHD. American Journal of Bioethics , 5(3), 34—47.
27.
Singh, I. (forthcoming). Children's involvement in research: Real versus imagined ethical challenges. EMBO Reports.
28.
Strauss, A., & Corbin, J. (1990). Basics of qualitative research: Grounded theory procedures and techniques. London: SAGE Publications.
29.
Taylor, C. (1991). The ethics of authenticity. Cambridge, MA: Harvard University Press.
30.
United Nations International Narcotics Control Board. (1999). Comments on reported statistics. New York: United Nations.
